1.Exploring the role of copine 1 in human colorectal cancer:investigating its association with tumorigenesis and metastasis
Jin-Kwon LEE ; Seung-Jun LEE ; Young-Sool HAH ; Yeong-Ho JI ; Young-Tae JU ; Young-Joon LEE ; Chi-Young JEONG ; Ju-Yeon KIM ; Ji-Ho PARK ; Jae-Myung KIM ; Jin-Kyu CHO ; Han-Gil KIM ; Seung-Jin KWAG
Annals of Surgical Treatment and Research 2023;105(6):385-395
		                        		
		                        			 Purpose:
		                        			This study aimed to investigate the potential role of copine-1 (CPNE1), a calcium-dependent membrane-binding protein encoded by the CPNE1 gene, in colorectal cancer (CRC). Despite previous research on the involvement of copine family members in various solid tumors, the specific role of CPNE1 in CRC remains poorly understood. 
		                        		
		                        			Methods:
		                        			We conducted clinicopathological analysis and functional studies to explore the impact of CPNE1 in human CRC.We examined the expression levels of CPNE1 in CRC patients and correlated it with invasive depth, lymph node metastasis, distant metastasis, lymphatic invasion, and TNM stage. Additionally, we performed experiments to assess the functional consequences of CPNE1 knockdown in CRC cells, including proliferation, colony formation, migration, invasion, and the expression of key regulators involved in the cell cycle and epithelial-mesenchymal transition (EMT). Furthermore, we evaluated the effects of CPNE1 knockdown on tumor growth using a xenograft mouse model. 
		                        		
		                        			Results:
		                        			High expression of CPNE1 was significantly associated with advanced tumor features in CRC patients. CPNE1 knockdown in CRC cells led to impaired abilities in proliferation, colony formation, migration, and invasion. Furthermore, CPNE1 silencing resulted in the suppression of protein expression related to the cell cycle and EMT. In the xenograft mouse model, CPNE1 knockdown inhibited tumor growth. 
		                        		
		                        			Conclusion
		                        			CPNE1 plays a crucial role in promoting tumorigenesis and metastasis in human CRC. By regulating the cell cycle and EMT, CPNE1 influences critical cellular processes at the membrane-cytoplasm interface. These results provide valuable insights into the potential development of novel therapeutic strategies for CRC targeting CPNE1. 
		                        		
		                        		
		                        		
		                        	
2.Draft genome of Semisulcospira libertina, a species of freshwater snail
Jeong-An GIM ; Kyung-Wan BAEK ; Young-Sool HAH ; Ho Jin CHOO ; Ji-Seok KIM ; Jun-Il YOO
Genomics & Informatics 2021;19(3):e32-
		                        		
		                        			
		                        			 Semisulcospira libertina, a species of freshwater snail, is widespread in East Asia. It is important as a food source. Additionally, it is a vector of clonorchiasis, paragonimiasis, metagonimiasis, and other parasites. Although S. libertina has ecological, commercial, and clinical importance, its whole-genome has not been reported yet. Here, we revealed the genome of S. libertina through de novo assembly. We assembled the whole-genome of S. libertina and determined its transcriptome for the first time using Illumina NovaSeq 6000 platform. According to the k-mer analysis, the genome size of S. libertina was estimated to be 3.04 Gb. Using RepeatMasker, a total of 53.68% of repeats were identified in the genome assembly. Genome data of S. libertina reported in this study will be useful for identification and conservation of S. libertina in East Asia. 
		                        		
		                        		
		                        		
		                        	
3.Two Types of Mouse Models for Sarcopenia Research: Senescence Acceleration and Genetic Modification Models
Kyung-Wan BAEK ; Youn-Kwan JUNG ; Jin Sung PARK ; Ji-Seok KIM ; Young-Sool HAH ; So-Jeong KIM ; Jun-Il YOO
Journal of Bone Metabolism 2021;28(3):179-191
		                        		
		                        			
		                        			Sarcopenia leads to loss of skeletal muscle mass, quality, and strength due to aging; it was recently given a disease code (International Classification of Diseases, Tenth Revision, Clinical Modification, M62.84). As a result, in recent years, sarcopenia-related research has increased. In addition, various studies seeking to prevent and treat sarcopenia by identifying the various mechanisms related to the reduction of skeletal muscle properties have been conducted. Previous studies have identified muscle synthesis and breakdown; investigating them has generated evidence for preventing and treating sarcopenia. Mouse models are still the most useful ones for determining mechanisms underlying sarcopenia through correlations and interventions involving specific genes and their phenotypes. Mouse models used to study sarcopenia often induce muscle atrophy by hindlimb unloading, denervation, or immobilization. Though it is less frequently used, the senescence-accelerated mouse can also be useful for sarcopenia research. Herein, we discuss cases where senescence-accelerated and genetically engineered mouse models were used in sarcopenia research and different perspectives to use them.
		                        		
		                        		
		                        		
		                        	
4.Two Types of Mouse Models for Sarcopenia Research: Senescence Acceleration and Genetic Modification Models
Kyung-Wan BAEK ; Youn-Kwan JUNG ; Jin Sung PARK ; Ji-Seok KIM ; Young-Sool HAH ; So-Jeong KIM ; Jun-Il YOO
Journal of Bone Metabolism 2021;28(3):179-191
		                        		
		                        			
		                        			Sarcopenia leads to loss of skeletal muscle mass, quality, and strength due to aging; it was recently given a disease code (International Classification of Diseases, Tenth Revision, Clinical Modification, M62.84). As a result, in recent years, sarcopenia-related research has increased. In addition, various studies seeking to prevent and treat sarcopenia by identifying the various mechanisms related to the reduction of skeletal muscle properties have been conducted. Previous studies have identified muscle synthesis and breakdown; investigating them has generated evidence for preventing and treating sarcopenia. Mouse models are still the most useful ones for determining mechanisms underlying sarcopenia through correlations and interventions involving specific genes and their phenotypes. Mouse models used to study sarcopenia often induce muscle atrophy by hindlimb unloading, denervation, or immobilization. Though it is less frequently used, the senescence-accelerated mouse can also be useful for sarcopenia research. Herein, we discuss cases where senescence-accelerated and genetically engineered mouse models were used in sarcopenia research and different perspectives to use them.
		                        		
		                        		
		                        		
		                        	
5.Genes Expressed in Steroid-exposed Lens Epithelial Cells as Revealed by Polymerase Chain Reaction
Woong-Sun YOO ; Jin-Seok SEO ; Yong Wun CHO ; Young-Sool HAH ; In Young CHUNG ; Seong Wook SEO ; Seong-Jae KIM
Journal of the Korean Ophthalmological Society 2020;61(5):472-481
		                        		
		                        			 Purpose:
		                        			We investigated the expression levels of 84 genes in dexamethasone-exposed human lens epithelial cells using polymerase chain reaction (PCR) array analysis. 
		                        		
		                        			Methods:
		                        			The viability and motility of lens epithelial cells were examined after treatment with dexamethasone at 0.01, 0.1, and 1 mg/mL; Western blot was used to evaluate the expression levels of fibronectin, α-smooth muscle actin (α-SMA), and E-cadherin. After 24, 48, and 72 hours of dexamethasone treatment at 0.1 mg/mL, the expression levels of 84 growth factors were analyzed using PCR array. 
		                        		
		                        			Results:
		                        			Cell viability did not change significantly at dexamethasone levels of 0.01 or 0.1 mg/mL, but decreased markedly at 1 mg/mL; motility increased in a concentration-dependent manner at 0.01 and 0.1 mg/mL. Western blot showed that fibronectin levels increased significantly at all dexamethasone concentrations tested; the α-SMA level increased only at 0.01 mg/mL, and E-cadherin levels decreased significantly at all tested concentrations. PCR showed that the levels of FGF1, FGF2, IL-11, regulators of apoptosis (GDNF, IL-1β, and NRG2), and regulators of cell differentiation (BMP5, FGF1, FGF2, and FGF5) decreased more than twofold, whereas the levels of FGF9 and FGF19 increased more than twofold. 
		                        		
		                        			Conclusions
		                        			PCR performed after exposure of lens epithelial cells to dexamethasone may identify the genes involved in the development of steroid-induced cataracts. 
		                        		
		                        		
		                        		
		                        	
6.Rodent Model of Muscular Atrophy for Sarcopenia Study
Kyung-Wan BAEK ; Youn-Kwan JUNG ; Ji-Seok KIM ; Jin Sung PARK ; Young-Sool HAH ; So-Jeong KIM ; Jun-Il YOO
Journal of Bone Metabolism 2020;27(2):97-110
		                        		
		                        			
		                        			 The hallmark symptom of sarcopenia is the loss of muscle mass and strength without the loss of overall body weight. Sarcopenia patients are likely to have worse clinical outcomes and higher mortality than do healthy individuals. The sarcopenia population shows an annual increase of ~0.8% in the population after age 50, and the prevalence rate is rapidly increasing with the recent worldwide aging trend. Based on International Classification of Diseases, Tenth Revision, a global classification of disease published by the World Health Organization, issued the disease code (M62.84) given to sarcopenia in 2016. Therefore, it is expected that the study of sarcopenia will be further activated based on the classification of disease codes in the aging society. Several epidemiological studies and meta-analyses have looked at the correlation between the prevalence of sarcopenia and several environmental factors. In addition, studies using cell lines and rodents have been done to understand the biological mechanism of sarcopenia. Laboratory rodent models are widely applicable in sarcopenia studies because of the advantages of time savings, cost saving, and various analytical applications that could not be used for human subjects. The rodent models that can be applied to the sarcopenia research are diverse, but a simple and fast method that can cause atrophy or aging is preferred. Therefore, we will introduce various methods of inducing muscular atrophy in rodent models to be applied to the study of sarcopenia. 
		                        		
		                        		
		                        		
		                        	
7.Overexpression of Neuron-Specific Enolase as a Prognostic Factor in Patients with Gastric Cancer.
Taejin PARK ; Young Joon LEE ; Sang Ho JEONG ; Sang Kyung CHOI ; Eun Jung JUNG ; Young tae JU ; Chi Young JEONG ; Miyeong PARK ; Young Sool HAH ; Jiyun YOO ; Woo Song HA ; Soon Chan HONG ; Gyung Hyuck KO
Journal of Gastric Cancer 2017;17(3):228-236
		                        		
		                        			
		                        			PURPOSE: Enolase is a cytoplasmic enzyme that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic pathway. The aim of this study was to investigate whether the overexpression of neuron-specific enolase (NSE) can serve as a prognostic factor in patients with gastric cancer (GC). MATERIALS AND METHODS: To assess its prognostic value in GC, NSE expression was measured by immunohistochemistry in a clinically annotated tissue microarray comprising of 327 human GC specimens. Cytoplasmic NSE expression was scored from 0 to 4, reflecting the percentage of NSE-positive cells. RESULTS: In terms of histology as per the World Health Organization criteria (P=0.340), there were no differences between the NSE overexpression (NSE-OE) and NSE underexpression (NSE-UE) groups. The NSE-OE group showed a significantly lower rate of advanced GC (P<0.010), lymph node metastasis (P=0.010), advanced stage group (P<0.010), cancer-related death (P<0.010), and cancer recurrence (P<0.010). Additionally, a Kaplan-Meier survival analysis revealed that the NSE-OE group had longer cumulative survival times than the NSE-UE group (log-rank test, P<0.010). However, there were no significant differences in the serum levels of NSE expression in patients with GC and healthy volunteers (P=0.280). CONCLUSIONS: Patients with NSE overexpressing GC tissues showed better prognostic results, implying that NSE could be a candidate biomarker of GC.
		                        		
		                        		
		                        		
		                        			Cytoplasm
		                        			;
		                        		
		                        			Healthy Volunteers
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Lymph Nodes
		                        			;
		                        		
		                        			Neoplasm Metastasis
		                        			;
		                        		
		                        			Phosphoenolpyruvate
		                        			;
		                        		
		                        			Phosphopyruvate Hydratase*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Stomach Neoplasms*
		                        			;
		                        		
		                        			World Health Organization
		                        			
		                        		
		                        	
8.Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation.
Seong Ji WOO ; Sang Myeong LEE ; Hye Song LIM ; Young Sool HAH ; In Duk JUNG ; Yeong Min PARK ; Hyun Ok KIM ; Yun Hong CHEON ; Min Gyu JEON ; Kyu Yun JANG ; Kyeong Min KIM ; Byung Hyun PARK ; Sang Il LEE
Experimental & Molecular Medicine 2016;48(3):e221-
		                        		
		                        			
		                        			The type III histone deacetylase silent information regulator 1 (SIRT1) is an enzyme that is critical for the modulation of immune and inflammatory responses. However, the data on its role in rheumatoid arthritis (RA) are limited and controversial. To better understand how SIRT1 regulates adaptive immune responses in RA, we evaluated collagen-induced arthritis (CIA) in myeloid cell-specific SIRT1 knockout (mSIRT1 KO) and wild-type (WT) mice. Arthritis severity was gauged on the basis of clinical, radiographic and pathologic scores. Compared with their WT counterparts, the mSIRT1 KO mice exhibited less severe arthritis, which was less destructive to the joints. The expression levels of inflammatory cytokines, matrix metalloproteinases and ROR-γT were also reduced in the mSIRT1 KO mice compared with the WT mice and were paralleled by reductions in the numbers of Th1 and Th17 cells and CD80- or CD86-positive dendritic cells (DCs). In addition, impaired DC maturation and decreases in the Th1/Th17 immune response were observed in the mSIRT1 KO mice. T-cell proliferation was also investigated in co-cultures with antigen-pulsed DCs. In the co-cultures, the DCs from the mSIRT1 KO mice showed decreases in T-cell proliferation and the Th1/Th17 immune response. In this study, myeloid cell-specific deletion of SIRT1 appeared to suppress CIA by modulating DC maturation. Thus, a careful investigation of DC-specific SIRT1 downregulation is needed to gauge the therapeutic utility of agents targeting SIRT1 in RA.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Arthritis
		                        			;
		                        		
		                        			Arthritis, Experimental*
		                        			;
		                        		
		                        			Arthritis, Rheumatoid
		                        			;
		                        		
		                        			Coculture Techniques
		                        			;
		                        		
		                        			Cytokines
		                        			;
		                        		
		                        			Dendritic Cells*
		                        			;
		                        		
		                        			Down-Regulation
		                        			;
		                        		
		                        			Histone Deacetylases
		                        			;
		                        		
		                        			Joints
		                        			;
		                        		
		                        			Matrix Metalloproteinases
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			T-Lymphocytes
		                        			;
		                        		
		                        			Th17 Cells
		                        			
		                        		
		                        	
9.Cytoprotective Mechanism of Cyanidin and Delphinidin against Oxidative Stress-Induced Tenofibroblast Death.
Dae Cheol NAM ; Young Sool HAH ; Jung Been NAM ; Ra Jeong KIM ; Hyung Bin PARK
Biomolecules & Therapeutics 2016;24(4):426-432
		                        		
		                        			
		                        			Age-related rotator cuff tendon degeneration is related to tenofibroblast apoptosis. Anthocyanins reduce oxidative stress-induced apoptotic cell death in tenofibroblasts. The current study investigated the presence of cell protective effects in cyanidin and delphinidin, the most common aglycon forms of anthocyanins. We determined whether these anthocyanidins have antiapoptotic and antinecrotic effects in tenofibroblasts exposed to H₂O₂, and evaluated their biomolecular mechanisms. Both cyanidin and delphinidin inhibited H₂O₂-induced apoptosis in a dose-dependent manner. However, at concentrations of 100 μg/ml or greater, delphinidin showed cytotoxicity against tenofibroblasts and a decreased antinecrotic effect. Cyanidin and delphinidin both showed inhibitory effects on the H₂O₂-induced increase in intracellular ROS formation and the activation of ERK1/2 and JNK. In conclusion, both cyanidin and delphinidin have cytoprotective effects on cultured tenofibroblasts exposed to H₂O₂. These results suggest that cyanidin and delphinidin are both beneficial for the treatment of oxidative stress-mediated tenofibroblast cell death, but their working concentrations are different.
		                        		
		                        		
		                        		
		                        			Anthocyanins
		                        			;
		                        		
		                        			Apoptosis
		                        			;
		                        		
		                        			Cell Death
		                        			;
		                        		
		                        			Rotator Cuff
		                        			;
		                        		
		                        			Tendons
		                        			
		                        		
		                        	
10.Inhibitory Effects for Rheumatoid Arthritis of Dietary Supplementation with Resveratrol in Collagen-induced Arthritis.
Yun Hong CHEON ; Hyun Ok KIM ; Young Sun SUH ; Jae Hyung HUR ; Wonyong JO ; Hye Song LIM ; Young Sool HAH ; Mi Jeong SUNG ; Dae Young KWON ; Sang Il LEE
Journal of Rheumatic Diseases 2015;22(2):93-101
		                        		
		                        			
		                        			OBJECTIVE: Resveratrol is well-known for its anti-inflammatory, anti-oxidant effects on several diseases. We investigated whether dietary supplementation with resveratrol may suppress joint inflammation and destruction in a mouse model of collagen-induced arthritis (CIA). METHODS: Mice were randomly divided into two groups; CIA mice with normal diet-fed and CIA mice fed a 0.05% resveratrol diet. The effect of resveratrol on arthritis was assessed by clinical scoring system. The plain radiographs of paws were obtained to evaluate the effects on preventing bone destruction. Joint inflammation, cartilage damage, and osteoclastic bone resorption were checked by staining with H&E, Safranin-O, and tartrate resistant acid phosphatase (TRAP). Levels of pro-inflammatory cytokines were checked by enzyme-linked immunosorbent assay. The level of expression of nuclear factor (NF)-kappaB was measured by electrophoretic mobility shift assay (EMSA). RESULTS: Dietary supplementation with resveratrol led to mitigated severity of arthritis compared to the normal diet group (6.7+/-0.8 vs. 2.7+/-0.6, p<0.01). Resveratrol-fed mice showed decreased bone destruction on radiograph (3.4+/-0.3 vs. 2.0+/-0.2, p<0.01), and showed significantly inhibited pathological changes (inflammation 2.0+/-0.3 vs.3.2+/-0.2, p<0.01; cartilage damage 1.5+/-0.3 vs. 3.2+/-0.2, p<0.01; pannus formation 1.4+/-0.3 vs. 3.0+/-0.3, p<0.01; erosion; 1.4+/-0.2 vs. 3.3+/-0.3, p<0.01). Generation of TRAP-positive osteoclasts was inhibited in the resveratrol-fed mice (55.3+/-12.7 vs. 3.27+/-0.8, p<0.01). Resveratrol-fed mice showed decreased levels of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6,monocyte chemoattractant protein 1, and the soluble receptor activator of NF-kappaB ligand in joint tissues and sera. Expression of NF-kappaB, measured by EMSA, was decreased in resveratrol-fed mice. CONCLUSION: Dietary supplementation with resveratrol mitigates inflammation and bone destruction in CIA mice.
		                        		
		                        		
		                        		
		                        			Acid Phosphatase
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antioxidants
		                        			;
		                        		
		                        			Arthritis
		                        			;
		                        		
		                        			Arthritis, Experimental*
		                        			;
		                        		
		                        			Arthritis, Rheumatoid*
		                        			;
		                        		
		                        			Bone Resorption
		                        			;
		                        		
		                        			Cartilage
		                        			;
		                        		
		                        			Cytokines
		                        			;
		                        		
		                        			Diet
		                        			;
		                        		
		                        			Dietary Supplements*
		                        			;
		                        		
		                        			Electrophoretic Mobility Shift Assay
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Interleukins
		                        			;
		                        		
		                        			Joints
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			NF-kappa B
		                        			;
		                        		
		                        			Osteoclasts
		                        			;
		                        		
		                        			Receptor Activator of Nuclear Factor-kappa B
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail